# Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

> **NCT04447222** · — · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1242 (estimated)

## Conditions studied

- COVID-19 Infection
- Malignant Solid Neoplasm

## Interventions

- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT04447222
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-05-12
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 1242 (ESTIMATED)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04447222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04447222, "Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04447222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*